Bellicum Pharmaceuticals, Inc.
(NASDAQ : BLCM)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.10%125.140.0%$2517.24m
BNGOBioNano Genomics, Inc. -11.93%8.050.0%$1626.30m
GILDGilead Sciences, Inc. 1.37%67.991.0%$696.88m
AMGNAmgen, Inc. 1.65%252.361.3%$574.64m
CRSPCRISPR Therapeutics AG -4.30%189.770.6%$516.52m
REGNRegeneron Pharmaceuticals, Inc. 1.57%542.272.7%$477.27m
ALXNAlexion Pharmaceuticals, Inc. -0.61%157.742.0%$471.04m
NVAXNovavax, Inc. -2.31%125.0592.9%$463.88m
ILMNIllumina, Inc. 3.42%403.543.5%$395.72m
SRPTSarepta Therapeutics, Inc. -0.04%96.7613.8%$351.95m
VRTXVertex Pharmaceuticals, Inc. 2.07%236.701.9%$351.25m
BIIBBiogen, Inc. -1.30%270.281.7%$328.68m
BNTXBioNTech SE -1.40%103.230.0%$308.28m
OCGNOcugen, Inc. -4.70%2.230.0%$294.71m
PACBPacific Biosciences of California, Inc. -4.02%38.597.4%$258.16m

Company Profile

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.